Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ENTROPY NEURODYNAMICS LIMITED Share Issue/Capital Change 2019

Jul 28, 2019

64855_rns_2019-07-28_3d69258a-2ccd-419f-97c1-a609def0d5a0.pdf

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

==> picture [595 x 77] intentionally omitted <==

ASX ANNOUNCEMENT

UPCOMING RELEASE OF SHARES FROM ESCROW

29[th] July 2019

In accordance with ASX Listing Rule 3.10A, Exopharm Limited (ASX:EX1) advises that a total of 959,401 fully paid ordinary shares will be released from escrow on 10 August 2019 and will be tradeable from 12 August 2019, being the next trading day after lapse of the escrow period.

An Appendix 3B applying for quotation of the fully paid ordinary shares being released from escrow will be announced shortly after the lapse of the escrow period.

ENDS.

1

EXOPHARM LIMITED ACN: 163 765 991 ASX:EX1 Address: Level 17, 31 Queen Street Melbourne 3000 Telephone: 03 9111 0026 Email: [email protected] Web: www.exopharm.com